| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/21/2002 | CA2418531A1 Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
| 02/21/2002 | CA2418455A1 Valproic acid derivatives for the treatment of pain |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2417821A1 Process for the preparation of imidazopyridines |
| 02/21/2002 | CA2417807A1 Process for the preparation of dinapsoline |
| 02/21/2002 | CA2416898A1 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | CA2416794A1 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | CA2413762A1 Compounds for the treatment of addictive disorders |
| 02/20/2002 | EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 02/20/2002 | EP1180366A1 Neuronal death inhibitors |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180094A1 Fused polycyclic amino acids as pharmaceutical agents |
| 02/20/2002 | EP1180058A1 Combinations of gaba analogs and tricyclic compounds to treat depression |
| 02/20/2002 | EP1180039A2 Factor for regulation of neurite growth |
| 02/20/2002 | EP1180036A1 Cell therapy for chronic stroke |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | EP0927171B1 Pyrazinones and triazinones and their derivatives thereof |
| 02/20/2002 | EP0917463B1 Tramadol multiple unit formulations |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | EP0792286B1 Peptide analogues at position 91 of human myelin basis protein for treatment of multiple scerosis |
| 02/20/2002 | EP0668763B1 Use of phenserine for the preparation of medicaments for the treatment of cognitive disorders |
| 02/20/2002 | CN1336959A Method for introducing substances into cells and use of said method |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336929A Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 02/20/2002 | CN1336926A Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336920A Telmisartan polymorphs, methods for producing same and their use in prepn. of a medicament |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336917A Amide compounds |
| 02/20/2002 | CN1336916A Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 02/20/2002 | CN1336821A Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their prepn. and therapeutic use |
| 02/20/2002 | CN1336369A Benzopyran compound, and its pharmaceutical use |
| 02/20/2002 | CN1336217A Traditional Chinese medicine prepn. for treating mental hypoevolutismus and senile dementia |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079261C Medicinal composition for abstaining from drugs and its prepn. method |
| 02/20/2002 | CN1079256C Medicinal composition for curing sleepless and amnesia |
| 02/20/2002 | CN1079251C Medicine for treating diseases of central nervous system |
| 02/20/2002 | CN1079244C Medicine for abstaining from drugs and its prepn. |
| 02/20/2002 | CN1079243C Medicine for treating cardiovascular disease and its prepn. technology |
| 02/20/2002 | CN1079240C Medicinal liquor for encephalic health and tonifying, and the prepn. thereof |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348498 Analgesics and cephalins |
| 02/19/2002 | US6348489 Method of treating traumatic brain injury and other neuronal disorders |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348458 Polymorphic forms of olanzapine |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/19/2002 | US6348211 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 02/19/2002 | CA2215343C Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 02/19/2002 | CA2112083C Aryl substituted heterocyclic compounds |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/18/2002 | CA2355411A1 Combination therapy using sympathetic nervous system antagonists and endothelin antagonists |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/14/2002 | WO2002070513A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012269A2 Pharmaceutical composition comprising an analgesic peptide |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012244A2 Polymorphs of zaleplon and methods for the preparation thereof |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012233A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012192A1 Quinolene derivatives as anti-inflammation agents |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012178A1 Compounds acting as melanocortin receptor ligands |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011779A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 02/14/2002 | WO2002011767A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 02/14/2002 | WO2002011765A1 COMBINATION PREPARATION WITH AN ERβ SELECTIVE ESTROGEN AND A SERM OR ANTIESTROGEN |
| 02/14/2002 | WO2002011750A2 Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway |
| 02/14/2002 | WO2002011742A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |